Showing results (241-250 of 391) with videos related to
Sort By:
Pageof 40
British Medical Journal (Clinical Research Ed.)|October 18, 1986
Visceral and skin granuloma annulare, diabetes, and polyendocrine diseaseD J Thomas, M Rademaker, D D Munro, et al.The Journal of Pharmacy and Pharmacology|August 1, 1989
Pharmacokinetic modelling of the effect of activated charcoal on the intestinal secretion of theophylline, using the isolated vascularly perfused rat small intestineM H de Vries, C M Rademaker, C Geerlings, et al.Plos One|July 11, 2020
The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic ReviewsMaaike M Rademaker, Geerte G J Ramakers, Adriana L Smit, et al.Nederlands Tijdschrift Voor Geneeskunde|June 29, 1991
[Magnesium poisoning in an infant]F G Versteegh, A J van Vught, J G vande Walle, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 16, 2015
Successful melanoma triage by a virtual lesion clinic (teledermatoscopy)A T Congalton, A M Oakley, M Rademaker, et al.Frontiers in Neurology|August 21, 2023
Development and internal validation of a prediction model for the presence of tinnitus in a Dutch population-based cohortMaaike M Rademaker, Adriana L Smit, Robert J Stokroos, et al.International Journal of Immunopharmacology|January 1, 1983
Effects of immunological adjuvants on the mouse complement system. I. The inability of the polyanion heparin to act as an adjuvant is paralleled by inefficient alternative complement pathway inhibitionJ P Klerx, H Van Dijk, H Damen, et al.Immunology Letters|January 1, 1985
Surface-associated sialic acid is an immunological adjuvantH van Dijk, P M Rademaker, J P Klerx, et al.The Science of the Total Environment|October 18, 2011
Noise measurements as proxies for traffic parameters in monitoring networksA Can, L Dekoninck, M Rademaker, et al.The British Journal of Dermatology|November 26, 2005
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trialG G Krueger, R G Langley, A Y Finlay, et al.Pageof 40